Thomas P. Haverty - Concepedia

Author

Thomas P. Haverty

Also Known As

T Haverty, T P Haverty, T. Haverty, T. P. Haverty, THOMAS P. HAVERTY, Thomas Haverty, Thomas P Haverty, Thomas P. Haverty

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania California University of Pennsylvania National Institute of Allergy and Infectious Diseases

About

Thomas P. Haverty is an author at University of Pennsylvania specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	945
2	Cell Biology	8	8	679
3	Cellular Physiology	5	5	291
4	Allergy	2	2	96
5	Diabetes	1	1	195

Thomas P. Haverty

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. Thomas P. Haverty, C J Kelly, William H. Hines, The Journal of Cell Biology Glomerular DiseaseRenal PathologyImmunologyPathologyImmunologic Mechanism	1988	306
High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule Fuad N. Ziyadeh, Edward R. Snipes, M. Watanabe, American Journal of Physiology-Renal Physiology Collagen BiosynthesisCellular PhysiologyHigh Glucose InducesRenal FunctionMetabolism	1990	195
Safety and efficacy of the monoclonal anti–interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome Amy D. Klion, Melissa Law, Pierre Noël, Blood	2003	162
A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION Douglas J. Norman, Lawrence Kahana, Frank P. Stuart, Transplantation	1993	158
Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines René Alvarez, Mae Jane Sun, Thomas P. Haverty, Kidney International	1992	111
Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700 Yae‐Jean Kim, Calman Prussin, Brian M. Martin, Journal of Allergy and Clinical Immunology ImmunologyGastroenterologyPathologyAutoimmunityClinical Gastroenterology	2004	111
Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. Hendrik Schulze‐Koops, Laurie S. Davis, Thomas P. Haverty, PubMed	1998	91
Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4 H. Bachelez, B. Flageul, Louis Dubertret, Journal of Autoimmunity Autoimmune DiseaseHumanized Non-depleting AntibodyMedicineSystemic TreatmentImmunology	1998	59
Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. C J Kelly, Robert Korngold, Richard A. Mann, The Journal of Immunology Glomerular DiseaseKidney CapsuleT-regulatory CellRenal PathologyImmunology	1986	50
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival Daniel Abramowicz, Douglas J. Norman, Pierre Vereerstraeten, Kidney International Transplantation SurgeryUrologyTransplantationKidney TransplantKidney Transplantation	1996	50

Page 1